Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,022 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Sputum culture conversion with moxifloxacin-containing regimens in the treatment of patients with newly diagnosed sputum-positive pulmonary tuberculosis in South India.
Velayutham BV, Allaudeen IS, Sivaramakrishnan GN, Perumal V, Nair D, Chinnaiyan P, Paramasivam PK, Dhanaraj B, Santhanakrishnan RK, Navaneethapandian GP, Marimuthu MK, Kumar V, Kandasamy C, Dharuman K, Elangovan T, Narasimhan M, Rathinam S, Vadivelu G, Rathinam P, Chockalingam C, Jayabal L, Swaminathan S, Shaheed JM. Velayutham BV, et al. Among authors: nair d. Clin Infect Dis. 2014 Nov 15;59(10):e142-9. doi: 10.1093/cid/ciu550. Epub 2014 Jul 14. Clin Infect Dis. 2014. PMID: 25028463 Clinical Trial.
Effect of moxifloxacin on QTc interval in adults with pulmonary tuberculosis.
Nair D, Velayutham B, Marimuthu M, Navaneethapandian PGD, Chinnaiyan P, Jawahar MS, Swaminathan S. Nair D, et al. Natl Med J India. 2018 Jan-Feb;31(1):58-59. doi: 10.4103/0970-258X.243427. Natl Med J India. 2018. PMID: 30348931 Free article. Clinical Trial. No abstract available.
4-month moxifloxacin containing regimens in the treatment of patients with sputum-positive pulmonary tuberculosis in South India - a randomised clinical trial.
Velayutham B, Jawahar MS, Nair D, Navaneethapandian P, Ponnuraja C, Chandrasekaran K, Narayan Sivaramakrishnan G, Makesh Kumar M, Paul Kumaran P, Ramesh Kumar S, Baskaran D, Bella Devaleenal D, Sirasanambati DR, Vasantha M, Palaniyandi P, Ramachandran G, Uma Devi KR, Elizabeth Hannah L, Sekar G, Radhakrishnan A, Kalaiselvi D, Dhanalakshmi A, Thiruvalluvan E, Raja Sakthivel M, Mahilmaran A, Sridhar R, Jayabal L, Rathinam P, Angamuthu P, Soorappa Ponnusamy K, Venkatesan P, Natrajan M, Prasad Tripathy S, Swaminathan S. Velayutham B, et al. Among authors: nair d. Trop Med Int Health. 2020 Apr;25(4):483-495. doi: 10.1111/tmi.13371. Epub 2020 Feb 3. Trop Med Int Health. 2020. PMID: 31944502 Free article. Clinical Trial.
Status of Universal Drug Susceptibility Testing in Pulmonary Tuberculosis Patients Initiated on Treatment in an Urban Setting, South India.
Velayutham B, Jayabal L, Watson B, Jagadeesan S, Suresh C, Nair D, Gopalaswamy R, Devaleenal B, Selvaraju S, Padmapriyadarsini C. Velayutham B, et al. Among authors: nair d. Indian J Community Med. 2023 Jan-Feb;48(1):103-107. doi: 10.4103/ijcm.ijcm_315_22. Epub 2023 Feb 1. Indian J Community Med. 2023. PMID: 37082398 Free PMC article.
Eumycetoma pedis due to Exophiala jeanselmei.
Capoor MR, Khanna G, Nair D, Hasan A, Rajni, Deb M, Aggarwal P. Capoor MR, et al. Among authors: nair d. Indian J Med Microbiol. 2007 Apr;25(2):155-7. doi: 10.4103/0255-0857.32726. Indian J Med Microbiol. 2007. PMID: 17582190
1,022 results